Zhao Y, Chen J, Zheng H, Luo Y, An M, Lin Y
Cancer Res. 2023; 84(3):434-448.
PMID: 37991737
PMC: 10831341.
DOI: 10.1158/0008-5472.CAN-23-2278.
Paul S, McCourt P, Le L, Ryu J, Czaja W, Bode A
bioRxiv. 2023; .
PMID: 37873235
PMC: 10592958.
DOI: 10.1101/2023.10.04.560876.
Shepelev N, Dontsova O, Rubtsova M
Int J Mol Sci. 2023; 24(5).
PMID: 36902458
PMC: 10003056.
DOI: 10.3390/ijms24055027.
Williard A, Switzer H, Howard C, Yin R, Russell B, Sanyal R
Pharmaceutics. 2022; 14(12).
PMID: 36559319
PMC: 9784311.
DOI: 10.3390/pharmaceutics14122826.
Gomarasca M, Lombardi G, Maroni P
Front Cell Dev Biol. 2022; 10:889002.
PMID: 35465332
PMC: 9020829.
DOI: 10.3389/fcell.2022.889002.
Protein post-translational modifications in the regulation of cancer hallmarks.
Wang H, Yang L, Liu M, Luo J
Cancer Gene Ther. 2022; 30(4):529-547.
PMID: 35393571
DOI: 10.1038/s41417-022-00464-3.
SUMOylation inhibition enhances multiple myeloma sensitivity to lenalidomide.
Du L, Liu W, Pichiorri F, Rosen S
Cancer Gene Ther. 2022; 30(4):567-574.
PMID: 35338347
PMC: 10104776.
DOI: 10.1038/s41417-022-00450-9.
SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma.
Du L, Liu W, Aldana-Masangkay G, Pozhitkov A, Pichiorri F, Chen Y
J Exp Clin Cancer Res. 2022; 41(1):8.
PMID: 34983615
PMC: 8725350.
DOI: 10.1186/s13046-021-02226-9.
Ubiquitination and degradation of SUMO1 by small-molecule degraders extends survival of mice with patient-derived tumors.
Bellail A, Jin H, Lo H, Jung S, Hamdouchi C, Kim D
Sci Transl Med. 2021; 13(615):eabh1486.
PMID: 34644148
PMC: 9450956.
DOI: 10.1126/scitranslmed.abh1486.
Therapeutic Potential of Targeting the SUMO Pathway in Cancer.
Kukkula A, Ojala V, Mendez L, Sistonen L, Elenius K, Sundvall M
Cancers (Basel). 2021; 13(17).
PMID: 34503213
PMC: 8431684.
DOI: 10.3390/cancers13174402.
Canonical NF-κB Promotes Lung Epithelial Cell Tumour Growth by Downregulating the Metastasis Suppressor CD82 and Enhancing Epithelial-to-Mesenchymal Cell Transition.
Roupakia E, Chavdoula E, Karpathiou G, Vatsellas G, Chatzopoulos D, Mela A
Cancers (Basel). 2021; 13(17).
PMID: 34503110
PMC: 8428346.
DOI: 10.3390/cancers13174302.
The E3 Ligase PIAS1 Regulates p53 Sumoylation to Control Stress-Induced Apoptosis of Lens Epithelial Cells Through the Proapoptotic Regulator Bax.
Nie Q, Chen H, Zou M, Wang L, Hou M, Xiang J
Front Cell Dev Biol. 2021; 9:660494.
PMID: 34195189
PMC: 8237824.
DOI: 10.3389/fcell.2021.660494.
Epigenetic Regulation in Breast Cancer.
Nam H, Baek S
Adv Exp Med Biol. 2021; 1187:103-119.
PMID: 33983575
DOI: 10.1007/978-981-32-9620-6_5.
SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer.
Chen C, Zheng H, Luo Y, Kong Y, An M, Li Y
J Clin Invest. 2021; 131(8).
PMID: 33661764
PMC: 8262506.
DOI: 10.1172/JCI146431.
SUMO and Transcriptional Regulation: The Lessons of Large-Scale Proteomic, Modifomic and Genomic Studies.
Boulanger M, Chakraborty M, Tempe D, Piechaczyk M, Bossis G
Molecules. 2021; 26(4).
PMID: 33562565
PMC: 7915335.
DOI: 10.3390/molecules26040828.
Molecular signature for senile and complicated cataracts derived from analysis of sumoylation enzymes and their substrates in human cataract lenses.
Liu F, Fu J, Wang L, Nie Q, Luo Z, Hou M
Aging Cell. 2020; 19(10):e13222.
PMID: 32827359
PMC: 7576240.
DOI: 10.1111/acel.13222.
SUMOylation of E2F1 Regulates Expression of EZH2.
Du L, Fakih M, Rosen S, Chen Y
Cancer Res. 2020; 80(19):4212-4223.
PMID: 32816857
PMC: 8741410.
DOI: 10.1158/0008-5472.CAN-20-1259.
Isoform-Specific Lysine Methylation of RORα2 by SETD7 Is Required for Association of the TIP60 Coactivator Complex in Prostate Cancer Progression.
Song H, Chu J, Park S, Im H, Park I, Kim H
Int J Mol Sci. 2020; 21(5).
PMID: 32120841
PMC: 7084544.
DOI: 10.3390/ijms21051622.
Identification of RUVBL1 and RUVBL2 as Novel Cellular Interactors of the Ebola Virus Nucleoprotein.
Morwitzer M, Tritsch S, Cazares L, Ward M, Nuss J, Bavari S
Viruses. 2019; 11(4).
PMID: 31018511
PMC: 6521077.
DOI: 10.3390/v11040372.
SUMOylation in Glioblastoma: A Novel Therapeutic Target.
Fox B, Janssen A, Estevez-Ordonez D, Gessler F, Vicario N, Chagoya G
Int J Mol Sci. 2019; 20(8).
PMID: 30991648
PMC: 6514907.
DOI: 10.3390/ijms20081853.